ArticleBMC nursing2025
Construction of the central symptom cluster management program for patients with lung cancer undergoing chemotherapy: a Delphi study.
Article in BMC nursing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Symptom management in cancer care: An evolutionary concept analysis for a digitally enabled collaborative framework.Asia-Pacific journal of oncology nursing · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundIn recent years, the incidence of cancer has been on the rise worldwide due to environmental pollution, poor lifestyle habits, and increasing medical diagnoses. In China, the incidence and mortality of lung cancer both rank first among malignant tumors. In the process of cancer diagnosis and treatment, patients with lung cancer undergoing chemotherapy experience a serious symptom burden. Inadequate symptom management will aggravate the physical and mental pain of patients and even delay or interrupt the treatment of the disease. Therefore, it is urgent to provide symptom management programs for medical staff and patients with lung cancer undergoing chemotherapy.
objectiveTo construct the central symptom cluster management program for patients with lung cancer undergoing chemotherapy (CSCMP).
methodsUnder the guidance of Symptom Management Theory (SMT), the draft program was formed in December 2023 through the clinical expert meeting based on the best evidence summary, and the final program was formed after two rounds of Delphi with 17 experts between December 2023 and March 2024. Descriptive statistics and consistency tests (Kendall's W) were used to analyze the data.
resultsThe final program consists of 12 items in 7 different dimensions. The 7 dimensions are intervention symptom, intervention method, intervention time, intervention content, intervention personnel, intervention place, and intervention form. The 12 items include intervention training, focus assessment, health guidance, diet nursing, psychological nursing, exercise intervention, Traditional Chinese Medicine (TCM) intervention, energy-saving skills, life nursing, environmental nursing, sleep hygiene, and follow-up. In both rounds of Delphi, the recovery rate (RR) was 100%, the expert authority coefficient (Cr) was 0.888, the coefficient of variation (CV) was 0.130-0.280 and 0.110-0.197, respectively, the Kendall's W was 0.467 and 0.523, respectively, and P < 0.05.
conclusionCSCMP established in this study is scientific and credible, has clinical operability, and can guide medical staff and patients with lung cancer undergoing chemotherapy to carry out symptom management in complex clinical environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.